Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - Liberty - Outstanding Awards (Details)

v3.24.3
Stock-Based Compensation - Liberty - Outstanding Awards (Details)
$ / shares in Units, shares in Thousands, $ in Millions
 9 Months Ended
Sep. 30, 2024
USD ($)
$ / shares
shares
Additional disclosures  
Total unrecognized compensation cost related to unvested equity awards | $ $ 15
Weighted average period of recognition related to unvested equity awards (in years) 2 years 1 month 6 days
Formula One Group | Common Class A  
Number of options  
Granted 0
Outstanding at end of period 0
Formula One Group | Common Class B  
Number of options  
Granted 0
Outstanding at end of period 0
Formula One Group | Common Class C  
Number of options  
Outstanding at beginning of period 6,599
Granted 87
Exercised (1,904)
Outstanding at end of period 4,782
Exercisable at end of period 3,904
WAEP  
Outstanding at beginning of period | $ / shares $ 37.62
Granted | $ / shares 72.53
Exercised | $ / shares 34.13
Outstanding at end of period | $ / shares 39.64
Exercisable at end of period | $ / shares $ 37.37
Additional disclosures  
Weighted average remaining life, outstanding 2 years 8 months 12 days
Weighted average remaining life, exercisable 2 years 4 months 24 days
Aggregate intrinsic value, outstanding | $ $ 181
Aggregate intrinsic value, exercisable | $ $ 156
Common stock reserved for issuance 4,800
Liberty Live Group | Common Class A  
Number of options  
Granted 0
Outstanding at end of period 0
Liberty Live Group | Common Class B  
Number of options  
Granted 0
Outstanding at end of period 0
Liberty Live Group | Common Class C  
Number of options  
Outstanding at beginning of period 1,652
Granted 71
Exercised (264)
Forfeited/Cancelled (10)
Outstanding at end of period 1,449
Exercisable at end of period 1,085
WAEP  
Outstanding at beginning of period | $ / shares $ 42.36
Granted | $ / shares 40.00
Exercised | $ / shares 38.95
Forfeited/Cancelled | $ / shares 42.29
Outstanding at end of period | $ / shares 42.86
Exercisable at end of period | $ / shares $ 43.77
Additional disclosures  
Weighted average remaining life, outstanding 3 years
Weighted average remaining life, exercisable 2 years 4 months 24 days
Aggregate intrinsic value, outstanding | $ $ 12
Aggregate intrinsic value, exercisable | $ $ 8
Common stock reserved for issuance 1,400